Profil
Michael Schaefer is currently the Director at 2cureX ApS since 2022.
Prior to this, he was the Co-Managing Director at Sysmex Europe SE and the Executive Vice President at Sysmex Corp.
He also served as an Independent Director at 2cureX AB from 2022 to 2024.
Aktive Positionen von Michael Schaefer
| Unternehmen | Position | Beginn |
|---|---|---|
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Direktor/Vorstandsmitglied | 01.01.2022 |
Ehemalige bekannte Positionen von Michael Schaefer
| Unternehmen | Position | Ende |
|---|---|---|
| 2CUREX AB | Direktor/Vorstandsmitglied | 04.01.2024 |
| SYSMEX CORPORATION | Corporate Officer/Principal | - |
Sysmex Europe SE
 Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SYSMEX CORPORATION | Health Technology |
| 2CUREX AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Sysmex Europe SE
Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Health Technology |
